Publications by authors named "S Oukrich"
Article Synopsis
- The study aimed to evaluate the short- and midterm results of catheter-directed thrombolysis (CDT) for treating acute lower limb ischemia (ALI), focusing on functional outcomes based on Rutherford classification.
- A total of 200 patients were analyzed, showing high initial clinical success rates and comparable complication rates between different Rutherford classes, with notable rates of reinterventions and amputations during follow-up.
- The findings suggest that successful initial treatment and less severe ischemia at presentation lead to better long-term functional outcomes for patients undergoing CDT.
Purpose: Acute lower limb ischemia (ALI) is a sudden decrease in arterial limb perfusion due to an arterial blockage, threatening limb and life. Catheter-directed thrombolysis (CDT) is a minimally invasive procedure to remove such obstructions. However, approximately one-third of patients endure a re-occlusion after successful CDT.
View Article and Find Full Text PDFObjective: Inconsistencies in outcome data of therapeutic strategies for acute lower limb ischaemia (ALI) have hindered the synthesis of findings. A core outcome set (COS) may offer a solution to this problem by defining a minimum set of outcomes that are considered essential to all stakeholders involved. The first step in developing a COS is to review the previously reported outcomes on various treatment strategies for ALI.
View Article and Find Full Text PDFObjective: Regular measurement of fibrinogen as dose guidance in catheter directed thrombolysis (CDT) for acute limb ischaemia (ALI) has recently been dropped from European guidelines based on inconsistent literature. This study aimed to determine whether low fibrinogen levels and high activated partial thromboplastin time (APTT) are associated with an increased major bleeding risk during CDT.
Methods: All consecutive patients treated with CDT for ALI in two Dutch hospitals between January 2004 and April 2021 were analysed retrospectively.